Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Efficacy of Education Programs in Patients With Chronic Airway Diseases [NA]
A completed clinical trial assessing the efficacy of education programs in patients with chronic airway diseases, including chronic obstruct…
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: Pharmacokinetics of Co-administration of Seretide 250 Diskus (HCP0910) and Spiriva Capsule for Inhalation (HGP1011) [Phase 1]
Phase 1 pharmacokinetics study evaluating co-administration of Seretide 250 Diskus (fluticasone propionate/salmeterol) and Spiriva Capsule f…
-
CLINICAL_TRIALS research · 2016-07-07Clinical Trial Update: Association Between Testosterone Levels and COPD Severity
A clinical trial update examining the association between testosterone levels and chronic obstructive pulmonary disease severity; no results…
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: An Evaluation Of PF-03715455 In Moderate To Severe Chronic Obstructive Pulmonary Disease [Phase 2]
Phase 2 trial evaluating PF-03715455 in moderate-to-severe chronic obstructive pulmonary disease was terminated; results were posted in 2016…
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Association Between Increased Oxidative Stress, Anti-Inflammatory Fatty Acid Formation, and Airway Infection in People With Asthma and Chronic Obstructive Pulmonary Disease
This completed clinical trial investigated the relationship between oxidative stress, anti-inflammatory fatty acid formation, and airway inf…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-07-06Clinical Trial Update: Endobronchial Valve in Patients With Heterogeneous Emphysema [NA]
Clinical trial update on the Endobronchial Valve for heterogeneous emphysema; the current status of the trial is unknown.
-
CLINICAL_TRIALS trial_result · 2016-06-30Clinical Trial Update: Glycopyrrolate/Formoterol Fumarate MDI Compared With Spiriva® as An Active Control in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease [Phase 2]
Phase 2 trial comparing a glycopyrrolate/formoterol fumarate metered-dose inhaler to Spiriva as an active control in moderate-to-severe COPD…
-
CLINICAL_TRIALS trial_result · 2016-06-28Clinical Trial Update: Evaluation of Umeclidinium Bromide in Combination With Fluticasone Furoate in COPD Subjects With an Asthmatic Component [Phase 2]
Phase 2 trial results evaluate umeclidinium bromide in combination with fluticasone furoate for COPD patients with an asthmatic component; r…
-
FDA approval · 2016-06-23FDA Approved: SPIRIVA HANDIHALER — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Spiriva HandiHALER (tiotropium bromide) submitted by Boehringer Ingelheim Pharmaceuticals, I…
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: Dialogue Aimed at Reducing Anxiety in Patients With Severe COPD [Phase 4]
A Phase 4 clinical trial evaluating a dialogue-based intervention to reduce anxiety in patients with severe chronic obstructive pulmonary di…
-
CLINICAL_TRIALS trial_result · 2016-06-21Clinical Trial Update: Effects of Iloprost on Pulmonary Hemodynamics and Oxygenation in Patients of Chronic Obstructive Pulmonary Disease During One-lung Ventilation [NA]
This completed clinical trial evaluated the effects of Iloprost on pulmonary hemodynamics and oxygenation in COPD patients undergoing one-lu…
-
CLINICAL_TRIALS research · 2016-06-20Clinical Trial Update: The Improving Care in Chronic Obstructive Lung Disease Study A Cluster Randomized Trial [NA]
A clinical trial update for the Improving Care in Chronic Obstructive Lung Disease study, a cluster randomized trial in COPD; the current st…
-
FDA approval · 2016-06-17FDA Approved: COMBIVENT RESPIMAT — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for Combivent Respimat (ipratropium bromide and albuterol) submitted by Boehringer Ingelheim Pharmac…
-
CLINICAL_TRIALS trial_result · 2016-06-17Clinical Trial Update: Telemedicine for Patients Suffering From COPD (Danish Telecare North Trial) [NA]
The Danish Telecare North Trial, studying telemedicine for patients with chronic obstructive pulmonary disease, has completed.
-
CLINICAL_TRIALS trial_result · 2016-06-16Clinical Trial Update: Mechanisms of Exercise Intolerance in Chronic Obstructive Pulmonary Disease [NA]
A completed clinical trial update examining the mechanisms of exercise intolerance in chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2016-06-15Clinical Trial Update: Comparison of Long-term Safety of the Combination Product QVA149A Against Placebo and Standard of Care Treatment in Chronic Obstructive Pulmonary Disease Patients With Moderate to Severe Airflow Limitation [Phase 3]
Phase 3 trial evaluating the long-term safety of the combined inhaler QVA149A compared with placebo and standard of care in chronic obstruct…
-
CLINICAL_TRIALS trial_result · 2016-06-15Clinical Trial Update: Perception of Symptom Variability in COPD
This entry reports the completion of a clinical trial conducted by AstraZeneca toward understanding how patients with chronic obstructive pu…
-
CLINICAL_TRIALS research · 2016-06-15Clinical Trial Update: Clinical Practice of AECOPD Management in China
An update on how acute exacerbations of chronic obstructive pulmonary disease are managed in clinical practice in China. The study is sponso…
-
CLINICAL_TRIALS research · 2016-06-13Clinical Trial Update: Effect of Magnesium Supplementation in COPD [NA]
This clinical trial update concerns magnesium supplementation for chronic obstructive pulmonary disease. No results or current status detail…
-
FDA approval · 2016-06-09FDA Approved: COMBIVENT RESPIMAT — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for Combivent Respimat (ipratropium bromide and albuterol) from Boehringer Ingelheim Pharmaceuticals…
-
FDA approval · 2016-06-09FDA Approved: STRIVERDI RESPIMAT — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for Striverdi Respimat (olodaterol inhalation spray) from Boehringer Ingelheim Pharmaceuticals, Inc.…
-
FDA approval · 2016-06-09FDA Approved: STIOLTO RESPIMAT — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for STIOLTO RESPIMAT (tiotropium bromide and olodaterol) from Boehringer Ingelheim Pharmaceutica…
-
FDA approval · 2016-06-09FDA Approved: SPIRIVA RESPIMAT — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Spiriva Respimat (tiotropium bromide inhalation spray) filed by Boehringer Ingelheim Pharmac…
-
CLINICAL_TRIALS trial_result · 2016-06-09Clinical Trial Update: Respiratory EMG for NIV Titration in Stable COPD Patients [NA]
The clinical trial investigating Respiratory EMG for NIV titration in stable COPD was terminated.
-
CLINICAL_TRIALS trial_result · 2016-06-08Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of CNTO6785 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease [Phase 2]
This update reports the completion of a Phase 2 study evaluating the safety and effectiveness of CNTO6785 in adults with moderate to severe …